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Objective: Brain perfusion can be assessed non-invasively by modern arterial spin labeling MRI. The FAIR (flow-sensitive 
alternating inversion recovery)-TrueFISP (true fast imaging in steady precession) technique was applied for regional 
assessment of cerebral blood flow in brain areas close to the skull base, since this approach provides low sensitivity to 
magnetic susceptibility effects. The investigation of the rhinal cortex and the amygdala is a potentially important feature 
for the diagnosis and research on dementia in its early stages.
Materials and Methods: Twenty-three subjects with no structural or psychological impairment were investigated. FAIR-
True-FISP quantitative perfusion data were evaluated in the amygdala on both sides and in the pons. A preparation of the 
radiofrequency FOCI (frequency offset corrected inversion) pulse was used for slice selective inversion. After a time delay of 
1.2 sec, data acquisition began. Imaging slice thickness was 5 mm and inversion slab thickness for slice selective inversion 
was 12.5 mm. Image matrix size for perfusion images was 64 x 64 with a field of view of 256 x 256 mm, resulting in a 
spatial resolution of 4 x 4 x 5 mm. Repetition time was 4.8 ms; echo time was 2.4 ms. Acquisition time for the 50 sets of 
FAIR images was 6:56 min. Data were compared with perfusion data from the literature.
Results: Perfusion values in the right amygdala, left amygdala and pons were 65.2 (± 18.2) mL/100 g/minute, 64.6 (± 
21.0) mL/100 g/minute, and 74.4 (± 19.3) mL/100 g/minute, respectively. These values were higher than formerly 
published data using continuous arterial spin labeling but similar to 
15O-PET (oxygen-15 positron emission tomography) 
data.
Conclusion: The FAIR-TrueFISP approach is feasible for the quantitative assessment of perfusion in the amygdala. Data are 
comparable with formerly published data from the literature. The applied technique provided excellent image quality, even 
for brain regions located at the skull base in the vicinity of marked susceptibility steps.
Index terms: Amygdala; Arterial Spin Labeling; FAIR TrueFISP; MR; Perfusion; Rhinal Cortex
Received October 29, 2010; accepted after revision May 19, 2011.
Corresponding author: Burkhard Ludescher, MD, Department of 
Diagnostic and Interventional Neuro-Radiology, Eberhard-Karls-
University, Hoppe-Seyler-Strasse 3, D-72076 Tübingen, Germany.
• Tel: (497071) 2986024 • Fax: (497071) 295638
• E-mail: burkhard.ludescher@med.uni-tuebingen.de
This is an Open Access article distributed under the terms of 
the Creative Commons Attribution Non-Commercial License 
(http://creativecommons.org/licenses/by-nc/3.0) which permits 
unrestricted non-commercial use, distribution, and reproduction in 
any medium, provided the original work is properly cited. 
Original Article
http://dx.doi.org/10.3348/kjr.2011.12.5.554
pISSN 1229-6929 · eISSN 2005-8330
Korean J Radiol 2011;12(5):554-558
INTRODUCTION
Brain function and activation is strongly correlated to 
blood supply and perfusion, respectively. These effects are 
known as neurovascular coupling (1). On the other hand, 
the cerebral blood flow (CBF) is altered in tumors (2) or in 
ischemic areas (3). Several approaches have been developed 
in the past for measuring regional cerebral blood flow 
(rCBF): positron emission tomography (PET), single photon Korean J Radiol 12(5), Sep/Oct 2011 kjronline.org 555
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emission computed tomography (SPECT), Xenon-enhanced 
computed tomography (XeCT), dynamic perfusion-computed 
tomography (PCT), contrast-enhanced MRI, and dynamic 
susceptibility contrast (DSC)-MRI highlight these methods. 
Those techniques use contrast agents and are therefore not 
completely non-invasive (4, 5), while Doppler ultrasound 
shows the limitations of the applicability in an intra-
cerebral areas. 
Arterial spin labeling (ASL) is a completely noninvasive 
technique for perfusion assessment using MRI. ASL 
techniques apply endogenous arterial water as tracer. The 
method consists of a preparation part and a data acquisition 
part. A commonly used preparation technique is the flow-
sensitive alternating inversion recovery (FAIR) method (6, 
7).
The most common image acquisition technique for ASL is 
echo planar imaging (EPI) (6-8), which is, unfortunately, 
highly sensitive to susceptibility artifacts occurring 
especially in areas with pronounced susceptibility 
differences such as the skull base.
An alternative image acquisition technique for ASL is 
the “true fast imaging in steady precession” (TrueFISP) 
sequence. This method is much less sensitive to 
susceptibility artifacts than EPI and delivers especially high 
image quality in areas prone to susceptibility effects such 
as the brain stem or other areas aside from the skull base. 
Boss et al. (9) compared the FAIR-TrueFISP sequence with 
the EPI method and found relevant differences in image 
quality.
Due to marked differences in susceptibility near the skull 
base with bone structures on one hand and air filled areas 
(sinus) on the other hand, CBF measures of the amygdala 
and hippocampus are technically challenging. 
Especially, the amygdala, hippocampus, and rhinonasal 
cortex are highly involved in the etiopathology of dementia 
(10). The aim of this study was the application of the FAIR-
TrueFISP method for quantitative determination of CBF in 
the amygdala/rhinonasal cortex bilaterally, and the brain 
stem (pons) (for comparison). Those techniques were 
applied in a clinical routine setup and the results were 
to be compared with perfusion data in the literature, and 
measured using different methodical approaches. 
MATERIALS AND METHODS
Subjects
The study was approved by the local ethics committee. 
The volunteers of this study were patients of our 
department, which underwent an MRI for different reasons. 
Twenty- three subjects participated after giving informed 
consent. All participants had no incidence for mental 
impairment like dementia or affections of structures at 
the basal brain. The cohort consisted of seven men and 16 
women, with an age range of 39 to 84 years and a mean of 
60 ± 13 years.
MR Scanner
The investigations were performed using a clinical 1.5 
Tesla whole-body MR scanner (Magnetom Sonata, Siemens 
Healthcare, Erlangen, Germany). The body coil was used 
for homogeneous radiofrequency (RF) transmission, while 
the 8-channel head-coil was used for signal detection. The 
gradient system operates with a maximum gradient strength 
of 40 mT/m and a slew rate of 200 T/m/s.
Anatomical FLAIR Imaging
T2-weighted anatomical images of the whole brain were 
recorded by means of a FLAIR (fluid attenuated inversion 
recovery)-sequence. The slab was oriented in the axial 
standard orientation along the crus anterior and posterior 
of the corpus callosum.
FAIR True-FISP Imaging
The amygdala was located in the FLAIR images and the 
selected slice for ASL imaging was oriented in the same 
way. So, the amygdala and rhinonasal cortex, as well as 
parts of the brain stem (pons), were covered by one image.
The FAIR-TrueFISP method has been previously described 
(11); in the FAIR preparation scheme, an adiabatic RF 
FOCI (frequency offset corrected inversion) pulse was 
used for slice selective inversion. A inversion time (TI) 
of 1.2 sec after the inversion pulse was chosen prior to 
each acquisition, and four FAIR preparation prescans were 
applied before data acquisition. Imaging slice thickness 
was 5 mm and inversion slab thickness for slice selective 
inversion was 12.5 mm. Image matrix size for perfusion 
images and T1 maps was 64 x 64 with a field of view of 
256 x 256 mm, resulting in a spatial resolution of 4 x 4 x 5 
mm. To reduce Gibbs ringing, a Hamming k-space filter was 
applied. For optimal perfusion contrast, a centric-reordered 
k-space acquisition scheme was used.
Each FAIR preparation was followed by a data recording 
of one slice. Repetition time was 4.8 ms, echo time was 2.4 
ms, and acquisition bandwidth of the TrueFISP sequence was Korean J Radiol 12(5), Sep/Oct 2011 kjronline.org 556
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651 Hz/pixel. Acquisition time for 50 sets of FAIR images 
was 6:56 min. Fat-saturation preparation and an excitation 
angle of 70° was applied. After FAIR-TrueFISP perfusion 
imaging, tissue equilibrium magnetization was measured by 
the acquisition of a conventional TrueFISP image using the 
mentioned parameters (without inversion pulse).
Image Processing and Data Analysis
Magnitude images with slice selective and global inversion 
were collected in two sets. Magnitude images of each set 
were averaged and the final images were subtracted on a 
standalone PC using a home-made Matlab (The Mathworks, 
Inc., Natick, MA) program. The quantitative perfusion maps 
were computed on a pixel-by-pixel basis from the analysis 
of the magnetization difference, ∆M, using Eq. [1] (6):
∆M(TI) = Msel(TI) - Mnon(TI) = 2M0TI
f
exp TI [1] λ T1
where M0 represents the tissue equilibrium magnetization 
per unit mass of the tissue, T1 is the longitudinal relaxation 
time of tissue, f is the perfusion rate (usually in mL/100 
g/minute), and λ is the blood-tissue water partition 
coefficient, which is assumed to have a constant value of 
90 mL/100 g/minute (12). The T1 value for the amygdala 
and arterial blood was set to 1.2 s. All pixels with perfusion 
values greater than 150 mL/100 g/minute were encoded 
to 0 mL/100 g/minute, since they represent vascular flow 
rather than tissue perfusion.
Three regions of interest (ROI) were defined: one in 
the pons, one in the left and one in the right amygdala. 
Figure 1 illustrates the localizations in a FLAIR image. Data 




One volunteer was investigated three times in one session 
with repositioning between the different experiments. 
After anatomical FLAIR Imaging the ASL experiments 
were planned in plane with the FLAIR images. Reliability 
measures were performed defining the above mentioned 
ROIs in the amygdala left and right and in the pons. The 
data revealed a standard deviation of 12% of mean in the 
pons and 5% and 8% in the right and left amygdala. Data 
are given in Table 1. 
Perfusion Data
Following perfusion values were derived: amygdala right 
65.2 (± 18.2) mL/100 g/minute, amygdala left 64.6 (± 
21.0) mL/100 g/minute, pons 74.4 (± 19.3) mL/100 g/
minute.
Table 2 illustrates the results of our study and compares 
them with selected former published data in the literature. 
Compared with PET measurements the values are a little 
higher but comparable. Other ASL experiments using 
continuous ASL with EPI acquisition revealed much lower 
values. Standard deviations are relatively high, but this has 
also been reported from PET measurements (13, 14).
( ( -
Fig. 1. Region of interest-positions. Positions of region of 
interests in axial slice.
Table 1. Data of Reproducibility Measure
Right Amygdala  Left Amygdala  Pons
Measure 1 63.0 54.6 74.7
Measure 2 67.6 63.2 90.6
Measure 3 69.7 62.8 73.8
Mean (± SD) 66.7 (± 3.3) 60.2 (± 4.8) 79.7 (± 9.4)
Note.— One volunteer was investigated three times and perfusion was determined in three region of interests. Values are given 
in mL/100 g/minute. SD = standard deviationKorean J Radiol 12(5), Sep/Oct 2011 kjronline.org 557
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Figure 2 shows a proton density weighted TrueFISP image 
and a perfusion weighted image of one individual for 
illustration.
DISCUSSION
In this study we applied the FAIR-True FISP technique 
in order to determine perfusion data in the amygdala with 
a completely non-invasive MRI technique. Most common 
approaches use EPI data acquisition to measure perfusion 
in the brain. This technique is much more sensitive to 
susceptibility artifacts than the True-FISP technique. Boss 
et al. (9) have shown that FAIR-TrueFISP is applicable at 
the skull base. The FAIR-TrueFISP imaging technique uses 
endogenous water as a tracer. Therefore it is a completely 
non-invasive method.
Scent impairment is one of the early symptoms in mild 
cognitive impairment (MCI), which is the early stage of 
dementia (13). Therefore structures of the rhino-nasal 
cortex and the amygdala seem to be strongly involved in the 
development of dementia. Hence, functional investigation 
of these structures is of great concern in the diagnosis 
of dementia, especially in early stages. In this study we 
employed this method to determine perfusion values in the 
amygdala in mentally healthy people. The acquired values 
were compared with published values from the literature.
Compared with Dai et al. (10) and Lee et al. (14) (Tables 
1, 2) who used continuous ASL for measuring perfusion, 
our values are much higher. But compared to PET-measures, 
which use radioactive labeled water (
15O) (15, 16), our 
values are very similar to the literature. However, the 
standard deviation of individual data is pronounced.
Thus, FAIR-True FISP has some advantages but also 
disadvantages. Compared to EPI, it is feasible to investigate 
brain structures in the vicinity to the skull base, because 
it is less sensitive to susceptibility changes. Second, it 
is feasible in the clinical routine as one doesn't need any 
additional technical equipment like continuous arterial 
spin labeling (CASL). Third, it is non invasive because it 
uses endogenous water as tracer, and one doesn't need any 
contrast agent. However, there are some disadvantages to 
be discussed. FAIR TrueFISP is very sensitive to water inflow 
effects. Therefore small vessels in the voxel of interest 
contribute to the perfusion signal and may therefore 
increase the CBF values artificially. This effect was already 
discussed by Boss et al. (9). And in our study, this feature 
may be of special importance due to many also small 
vessels at the skull base. This effect explains the higher 
values compared to the other CASL studies. On the other 
hand, the present values are comparable with the PET data 
from literature. PET is still meant to be the gold standard in 
perfusion measures. So our measures are probably nearer to 
reality than the published CASL measures. Both, the present 
data, and also the formerly published data concerning the 
PD-Weighted Image Perfusion-Weighted Image
Fig. 2. Proton density (PD) weighted and perfusion weighted 
images.
Table 2. Published Perfusion Data in the Literature
Citation Location Method Perfusion mL/100 g/min (± SD)
Current study Right amygdala FAIR-TrueFISP 65.2 (± 18.2)
Current study Left amygdala FAIR-TrueFISP 64.6 (± 21.0)
Current study Pons FAIR-TrueFISP 74.4 (± 19.3)
Dai et al., 2009 (10) Right amygdala CASL (EPI) 38.91 (± 10.71)
Giovacchini et al., 2007 (15) Amygdala (both sides)
15O PET 67 (± 21) – 74 (± 20)
Schneider et al., 1995 (16) Right amygdala
15O PET 53.19 (± 22.06)
Schneider et al., 1995 (16) Left amygdala
15O PET 57.59 (± 23.58)
Lee et al., 2009 (14) Amygdala (both sides) CASL (EPI) 36.62
Note.— Data from previously published literature with absolute perfusion data at skull base, especially in amygdala and brain 
stem. 
15O PET = oxygen-15 positron emission tomography, CASL = continuous arterial spin labeling, EPI = echo planar imaging, 
FAIR-TrueFISP = flow-sensitive alternating inversion recovery-true fast imaging in steady precession Korean J Radiol 12(5), Sep/Oct 2011 kjronline.org 558
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amygdale, showed very high amounts of variance. Standard 
deviations are very high in all cases (Table 2). Thus FAIR-
TrueFISP is not worse than other more elaborated methods.
Another shortcoming of the present study is a wide range 
of age in the study samples. Due to a small sample size, 
we did not correct the data for age. But in elderly people 
lower perfusion values would be expected than in younger 
persons, independent from dementia (17). Therefore, to 
consolidate the results, and to analyse correlations with 
age, further studies will be necessary. 
Further studies will also be necessary to investigate the 
clinical value of FAIR-True-FISP in functional perfusion 
studies. But it seems to be a dedicated method for the use 
at the skull base.
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